Reports for APO-LANSOPRAZOLE
Brand name
APO-LANSOPRAZOLE
Company Name
Drug Identification Number
02293838
Ingredients & Strength
Anatomical Therapeutical Chemical (ATC) Code
- A02BC
Anatomical Therapeutical Chemical (ATC) Descriptor
- DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Status
MARKETED
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-LANSOPRAZOLE | 100 BTL | Resolved | 2020-10-28 | 2020-11-09 | 127350 |
| APO-LANSOPRAZOLE | 500 BTL | Resolved | 2021-04-30 | 2021-05-26 | 138346 |
| APO-LANSOPRAZOLE | 500 BTL | Resolved | 2022-02-18 | 2022-05-06 | 155317 |
| APO-LANSOPRAZOLE | 100 BTL | Resolved | 2022-12-16 | 2023-03-16 | 178751 |
| APO-LANSOPRAZOLE | 500 BTL | Resolved | 2023-01-20 | 2023-01-26 | 181970 |
| APO-LANSOPRAZOLE | 500 BTL | Resolved | 2023-02-09 | 2023-03-16 | 184089 |
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0